Fruquintinib
Overview
Fruquintinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4303214).
API suppliers (2)
Suppliers of Fruquintinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 2 hold a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Granules India LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Fruquintinib expires 7 Sept 2035 and exclusivity 8 Nov 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide
- Canonical SMILES
- CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC
- InChIKey
- BALLNEJQLSTPIO-UHFFFAOYSA-N
Do you supply Fruquintinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.